Nano-X Imaging Ltd. (NNOX)
NASDAQ: NNOX · IEX Real-Time Price · USD
7.64
-0.42 (-5.21%)
At close: Jul 19, 2024, 4:00 PM
7.83
+0.19 (2.49%)
Pre-market: Jul 22, 2024, 7:23 AM EDT
Nano-X Imaging Revenue
Nano-X Imaging had revenue of $10.01M in the twelve months ending March 31, 2024, with 8.61% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.55M with 4.33% year-over-year growth. In the year 2023, Nano-X Imaging had annual revenue of $9.91M with 15.47% growth.
Revenue (ttm)
$10.01M
Revenue Growth
+8.61%
P/S Ratio
44.09
Revenue / Employee
$61,043
Employees
164
Market Cap
441.43M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 9.91M | 1.33M | 15.47% |
| Dec 31, 2022 | 8.58M | 7.27M | 557.82% |
| Dec 31, 2021 | 1.30M | - | - |
| Dec 31, 2020 | 0 | - | - |
| Dec 31, 2019 | 0 | - | - |
| Dec 31, 2018 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bioventus | 522.74M |
| Health Catalyst | 296.79M |
| Pacific Biosciences of California | 200.43M |
| Voyager Therapeutics | 119.04M |
| Taysha Gene Therapies | 14.16M |
| Absci | 5.35M |
| Altimmune | 410.00K |
NNOX News
- 26 days ago - Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of Cardiovascular Computed Tomography - GlobeNewsWire
- 6 weeks ago - Nvidia Owns These 4 Stocks. Here's How They're Doing. - Barrons
- 6 weeks ago - Nanox Launches Artificial Intelligence Functionality in Second Opinions Platform - GlobeNewsWire
- 7 weeks ago - Nanox Announces First Quarter of 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Nanox to Report First Quarter and Financial Results on May 28, 2024 - GlobeNewsWire
- 2 months ago - USARAD, Nanox's Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission - GlobeNewsWire
- 3 months ago - Nanox Files 2023 Annual Report on Form 20-F - GlobeNewsWire
- 3 months ago - Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market - GlobeNewsWire